RTS,S/AS01 vaccine (Mosquirix™): an overview
Malaria is an illness caused by Plasmodium parasites transmitted to humans by infected mosquitoes. Of the five species that infect humans, P. falciparum exacts the highest toll in terms of human morbidity and mortality, and therefore represents a major public health threat in endemic areas. Recent a...
Main Author: | Matthew B. Laurens |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-03-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2019.1669415 |
Similar Items
-
Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
by: Hassan Mumtaz, et al.
Published: (2023-06-01) -
Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature
by: Abdullah Nadeem, et al.
Published: (2023-01-01) -
Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
by: Arora N, et al.
Published: (2021-03-01) -
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
by: Philippe Moris, et al.
Published: (2018-01-01) -
Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan
by: Shima Mahmoudi, et al.
Published: (2017-09-01)